side effects of tirzepatide and semaglutide vs Why You Might Tolerate One

Strength of recommendation: 2C Rationale: Venous thromboembolism, which includes deep vein thrombosis and pulmonary embolism (PE), is also an indication of anticoagulation.141,142 There is an increased risk of venous thromboembolism both in patients with diabetes143 as well as in those with CKD,144 where the risk of venous thromboembolism increases as kidney function declines.144 Furthermore, diabetes mellitus and CKD are risk factors for recurrent venous thromboembolism.44,45 Among deep vein thrombosis, unprovoked deep vein thrombosis refers to venous thrombosis in the absence of identifiable risk factors

This date is determined by the compounding pharmacy based on stability data for the specific formulation and should be strictly observed

Brain Pathol (2014) 24(3):2619

Safety and Tolerability of Glucagon-Like Peptide-1 Receptor Agonists Utilizing Data from the Exenatide Clinical Trial Development Program